Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-18T05:52:30.822Z Has data issue: false hasContentIssue false
  • English
  • Français

Lipotropin, Melanotropin and Endorphin: In Vivo Catabolism and Entry into Cerebrospinal Fluid

Published online by Cambridge University Press:  18 September 2015

P.D. Pezalla ,
M. Lis ,
N.G. Seidah  and
M. Chrétien
P.D. Pezalla*
Affiliation:
Clinical Research Institute of Montreal, Affiliated to the Universite de Montréal and the Hôtel-Dieu de Montreal
M. Lis
Affiliation:
Clinical Research Institute of Montreal, Affiliated to the Universite de Montréal and the Hôtel-Dieu de Montreal
N.G. Seidah
Affiliation:
Clinical Research Institute of Montreal, Affiliated to the Universite de Montréal and the Hôtel-Dieu de Montreal
M. Chrétien
Affiliation:
Clinical Research Institute of Montreal, Affiliated to the Universite de Montréal and the Hôtel-Dieu de Montreal
*
Clinical Research Institute of Montreal, 110 avenue des Pins ouest, Montreal, Quebec H2W 1R7, Canada.
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Anesthetized rabbits were given intravenous injections of either beta-lipotropin (beta-LPH), betamelanotropin (beta-MSH) or betaendorphin. The postinjection concentrations of these peptides in plasma and cerebrospinal fluid (CSF) were measured by radioimmunoassay (RIA). The plasma disappearance half-times were 13.7 min for beta-LPH, 5.1 min for beta-MSH, and 4.8 min for beta-endorphin. Circulating beta-LPH is cleaved to peptides tentatively identified as gamma-LPH and beta-endorphin. Each of these peptides appeared in the CSF within 2 min postinjection. The maximum CSF to plasma ratios were 0.08 for beta-LPH, 1.48 for beta-MSH, and 0.23 for beta-endorphin.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 5 , Issue 2 , May 1978 , pp. 183 - 188
Copyright
Copyright © Canadian Neurological Sciences Federation 1978

References

REFERENCES

Austen, B.M. and Smyth, D.G. (1977), The NH2-Terminus of C-fragment is resistant to the action of aminopeptidases. Biochemical and Biophysical Research Communications 76. 477–482.CrossRefGoogle Scholar
Belluzzi, J.D., Grant, N., Garsky, V., Sarantakis, D., Wise, C.D. and Stein, L. (1976). Analgesia induced in vivo by central administration of enkephalin in rat. Nature 260, 625–626.CrossRefGoogle ScholarPubMed
Bloom, F., Segal, D., Ling, N. and Guillemin, R. (1976). Endorphins: Profound behavioral effects in rats suggest new ethiological factors in mental illness. Science 194. 630–632.CrossRefGoogle Scholar
Bradbury, A.F., Smyth, D.G. and Snell, C.R. (1976). Lipotropin: precursor to two biologically active peptides. Biochemical and Biophysical Research Communications 69, 950–956.CrossRefGoogle ScholarPubMed
Bradbury, A.F., Smyth, D.G., Snell, C.R., Deakin, J.F.W. and Wendlandt, S. (1977). Comparison of the analgesic properties of lipotropin C-fragment and stabilized enkephalins in the rat. Biochemical and Biophysical Research Communications 74, 748–754.CrossRefGoogle ScholarPubMed
Buscher, H.H., Hill, R.Cromer, D., Cardinaux, F., Closse, A., Hauser, D. and Pless, J. (1976). Evidence for analgesic activity of enkephalin in the mouse. Nature 261, 423–425.CrossRefGoogle ScholarPubMed
Chrétien, M. (1973). Lipotropins. In: Methods in Investigative and Diagnostic Endocrinology (Berson, S.A. and Yalow, R.S., eds.) pp. 617–632, North Holland Publishing Co., Amsterdam.Google Scholar
Chrétien, M., Benjannet, S., Dragon, N., Seidah, N.G. and Lis, M. (1976). Isolation of peptides with opiate activity from sheep and human pituitaries: Relationship to beta-lipotropin. Biochemical and Biophysical Research Communica-tions, 72, 472–478.CrossRefGoogle ScholarPubMed
Crine, P., Benjannet, S., Seidah, N.G., Lis, M. and Chrétien, M. (1977). In vitro biosynthesis of beta-endorphin, gamma-lipotropin and beta-lipotropin by the pars intermedia of beef pituitary glands. Proceedings of the National Academy of Science, USA 74, 4276–4280.CrossRefGoogle ScholarPubMed
Ferrari, W., Gessa, G.L. and Vargin, L. (1963). Behavioral effects induced by intracisternally injected ACTH and MSH. Annals of the New York Academy of Sciences, 104. 330–343.CrossRefGoogle ScholarPubMed
Gispen, W.H., Wiegant, V.M., Bradbury, A.F., Hulme, E.C, Smyth, D.G. and Snell, C.R. (1976). Induction of excessive grooming in the rat by fragments of lipotropin. Nature 264, 794–795.CrossRefGoogle ScholarPubMed
Goldstein, A. (1976). Opioid peptides (endorphins) in pituitary and brain. Science 193, 1081–1086.CrossRefGoogle ScholarPubMed
Goldstein, A. and Cox, B.M. (1977). Opioid peptides (endorphins) in pituitary and brain. Psychoneuroendocrinology 2, 11–16.CrossRefGoogle ScholarPubMed
Graf, L., Szekely, J.I., Ronai, A.Z., Dunai-Kovacs, Z., and Bajusz, S. (1976). Comparative study on analgesic effect of Met5-enkephalin and related lipotropin fragments. Nature 263, 240–241.CrossRefGoogle ScholarPubMed
Guillemin, R., Ling, N. and Vargo, T. (1977). Radioimmunoassays for alpha-endorphin and beta-endorphin. Biochemical and Biophysical Research Communications, 77, 361–366.CrossRefGoogle ScholarPubMed
Jacquet, Y.F. and Marks, N. (1976). The C-fragment of beta-lipotropin: An endogenous neuroleptic or antipsychotogen. Science 194, 632–635.CrossRefGoogle ScholarPubMed
Kastin, A.J., Miller, L.H., Nockton, R., Sandman, C.A., Schally, A.V. and Stratton, L.O. (1973). Behavioral aspects of MSH. Progress in Brain Research 39, 468–470.Google ScholarPubMed
Kastin, A.J., Nissen, C, Nikolics, K., Medzihradszky, K.Coy, D.H., Teplan, I. and Schally, A.V. (1976a). Distribution of 3H-alpha-MSH in rat brain. Brain Research Bulletin 1, 19–26.CrossRefGoogle ScholarPubMed
Kastin, A.J., Nissen, C, Schally, A.V. and Coy, D.H. (1976b). Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog. Brain Research Bulletin 1, 583–589.CrossRefGoogle Scholar
Kastin, A.J., Sandman, C.A., Miller, L.H. and Schally, A.V. (1976c). Some questions related to melanocyte-stimulating hormone. Mayo Clinic Proceedings. 51, 632–636.Google ScholarPubMed
Krivoy, W., Kroeger, D., Taylor, A.N. and Zimmermann, E. (1974). An-tagonism of morphine by beta-melanocyte-stimulating hormone and by tetracosactin. European Journal of Pharmacology 27, 339–345.CrossRefGoogle ScholarPubMed
Krivoy, W., Kroeger, D.C. and Zimmermann, E. (1977). Neuropeptides: Influence of acute and chronic effects of opiates. Psychoneuroendocrinology 21, 43–51.CrossRefGoogle Scholar
Labella, F., Downey, G., Queen, G. and Pinsky, C. (1976). Endorphin activity in anterior, intermediate, and posterior pituitary. Canadian Journal of Physiology and Pharmacology 54, 946–948.CrossRefGoogle ScholarPubMed
Labella, F., Queen, G. and Sensyshyn, J. (1977). Lipotropin: Localization by radioimmunoassay of endorphin precursor in pituitary and brain. Biochemical and Biophysical Research Communications 75, 350–357.CrossRefGoogle ScholarPubMed
Li, C.H., Barnafi, L., Chrétien, M. and Chung, D. (1965). Isolation and amino acid sequence of beta-LPH from sheep pituitary glands. Nature 208, 1093–1094.CrossRefGoogle ScholarPubMed
Long, J., Krivoy, W. and Guillemin, R. (1961). On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the mammalia: enzymatic inactivation in vitro of beta-MSH by brain tissue. Endocrinology 69, 176–181.CrossRefGoogle ScholarPubMed
Marks, N., Grynbaum, A. and Neidle, A. (1977). On the degradation of enkephalins and endorphins by rat and mouse brain extracts. Biochemical and Biophysical Research Communications 74, 1552–1559.CrossRefGoogle ScholarPubMed
Motomatsu, T., Lis, M., Seidah, N.G. and Chrétien, M. (1976). Cataleptic effect of 61-91 beta-lipotropin in rat. Clinical Research 24, 660A.Google Scholar
Oliver, C, Mical, R.S. and Porter, J.C. (1977). Hypothalamic-pituitary vasculature: Evidence for retrograde blood flow in the pituitary stalk. Endocrinology 101, 598–604.CrossRefGoogle ScholarPubMed
Pert, C.B., Pert, A., Chang, J.K. and Fong, B.T.W. (1976). (D-Ala2)-Met-enkephalinamide: A potenl, long-lasting synthetic pentapeptide analgesic. Science 194, 330–332.CrossRefGoogle ScholarPubMed
Pezalla, P.D., Clarke, W.C, Lis, M. and Chrétien, M. (1978). Immunological characterization of beta-lipotropin fragments (endorphin, beta-MSH and N-fragment) from fish pituitaries. General and Comparative Endocrinology (in Press).CrossRefGoogle ScholarPubMed
Plotnikoff, N.P., Kastin, A.J., Coy, D.H., Christensen, C.W., Schally, A.V. and Spirtes, M.A. (1976). Neuropharmacological actions of enkephalin after systemic administration. Life Sci-ences 19, 1283–1288.CrossRefGoogle ScholarPubMed
Queen, G., Pinsky, C. and Labella, F. (1976). Subcellular localization of endorphin activity in bovine pituitary and brain. Biochemical and Biophysical Research Communications 72, 1021–1027.CrossRefGoogle ScholarPubMed
Rudman, D., Scott, J.W., Delrio, A.E., Houser, D.H. and Sheen, S. (1974). Effect of melanotropic peptides on protein synthesis in mouse brain. American Journal of Physiology. 226, 687–692.CrossRefGoogle ScholarPubMed
Sandman, C.A., George, J., McCanne, T.R., Nolan, J.D., Kaswan, J. and Kastin, A.J. (1977). MSH/ACTH 4-10 influences behavioral and physiological measures of attention. Journal of Clinical Endocrinology and Metabolism 44, 884–891.CrossRefGoogle ScholarPubMed
Sandman, C.A., Miller, L.H., Kastin, A.J. and Schally, A.V. (1972). Neuroendocrine influences on attention and memory. Journal of Comparative Physiological Psychology 80, 54–58.CrossRefGoogle ScholarPubMed
Scherrer, H., Lis, M., Seidah, N.G. and Chrétien, M. (1977). Hypophyse et peptides morphinomimétiques. Union Méd. Can. 106, 542–552Google Scholar
Seidah, N.G., Lis, M., Gianoulakis, C, Routhier, R., Benjannet, S.Schiller, P.W. and Chrétien, M. (1977). Morphine-like activity of sheep beta-lipotropin and its tryptic fragments. Canadian Journal of Biochemistry 55, 35–40.CrossRefGoogle ScholarPubMed
Smith, A.G., and Shuster, S. (1976). Immunoreacti ve beta-melanocytes-stimulating hormone in cerebrospinal fluid. The Lancet 1, 1321–1322.CrossRefGoogle Scholar
Tseng, L.F., Loh, H.H. and Li, C.H. (1976). Beta-endorphin as a potent analgesic by intravenous injection. Nature 263, 239–240.CrossRefGoogle ScholarPubMed
Tseng, L.F., Loh, H.H. and Li, C.H. (1977). Human beta-endorphin: Development of tolerance and behavioral activity in rats. Biochemical and Biophysical Research Communications. 74, 390–396.CrossRefGoogle ScholarPubMed